KS176 is primarily utilized in the field of biomedical research, particularly in studies focusing on cancer therapy. It functions as a selective inhibitor of certain proteins or enzymes that are involved in the growth and proliferation of cancer cells. Researchers employ KS176 to investigate its potential in disrupting signaling pathways that contribute to tumor development, aiming to develop targeted treatments with reduced side effects compared to conventional chemotherapy. Its application extends to preclinical studies, where it is tested in cellular and animal models to evaluate its efficacy and safety profile before advancing to clinical trials.